The efficacy of gabapentin combined with opioids for neuropathic cancer pain: a meta-analysis

BACKGROUND: More than 30% of cancer patients experience neuropathic pain. Opioids, as standard pain-relief agents, cannot achieve satisfactory outcomes to treat neuropathic cancer pain due to drug resistance and side effects. Meanwhile, gabapentin, a third-generation anticonvulsant drug, has great p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Hainan, Wu, Zhouyue, Wang, Qinxin, Wang, Jiatong, Zhang, Li, Meng, Lingtong, Han, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798151/
https://www.ncbi.nlm.nih.gov/pubmed/35116397
http://dx.doi.org/10.21037/tcr-20-2692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798151/
https://www.ncbi.nlm.nih.gov/pubmed/35116397
http://dx.doi.org/10.21037/tcr-20-2692

Ejemplares similares